LNTH INVESTOR ALERT: Lantheus Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD LLP

Core Viewpoint - The Lantheus class action lawsuit alleges that Lantheus Holdings, Inc. and its executives misled investors regarding the company's revenue outlook and growth potential, particularly concerning its key product, Pylarify, leading to significant stock price declines following disappointing financial results [1][4][5][6]. Group 1: Lawsuit Details - The lawsuit, titled Margolis v. Lantheus Holdings, Inc., seeks to represent purchasers of Lantheus securities and claims violations of the Securities Exchange Act of 1934 [1]. - The complaint highlights that Lantheus's key product, Pylarify, is a PET imaging agent used for diagnosing and treating prostate cancer [3]. - Allegations include that Lantheus executives created a false impression of the company's revenue potential while downplaying risks from competition and market dynamics [4]. Group 2: Financial Performance and Stock Impact - On May 7, 2025, Lantheus reported a year-over-year decrease in Pylarify sales, leading to a reduction in full-year growth projections from low-single-digit to flat-to-low single-digit percent growth, resulting in a stock price drop of over 23% [5]. - On August 6, 2025, Lantheus announced further disappointing results, with Pylarify sales down 8.3% year-over-year, and slashed fiscal year 2025 growth projections, causing the stock price to fall nearly 29% [6]. Group 3: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Lantheus securities during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. - The lead plaintiff can select a law firm to litigate the case and does not need to be the lead plaintiff to share in any potential recovery [7]. Group 4: About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having secured over $2.5 billion for investors in 2024 alone [8]. - The firm has been recognized for its significant recoveries in securities class action cases, including the largest recovery in history of $7.2 billion in the Enron case [8].